Inclusion body myositis pipeline market landscape report 2025 featuring abcuro, regeneron pharmaceuticals, and vandria

Dublin, march 05, 2025 (globe newswire) -- the "inclusion body myositis - pipeline insight, 2025" report has been added to researchandmarkets.com's offering. this report offers in-depth insights into the inclusion body myositis (ibm) pipeline, showcasing the continuing efforts of over 2 companies and the development of more than 3 pipeline drugs projected until 2025. the report delineates a comprehensive analysis of both clinical and nonclinical stage products, with an emphasis on therapeutic assessments by product type, stage, route of administration, and molecule type.
REGN Ratings Summary
REGN Quant Ranking